Experienced in Brain Tumor

Hiroki Shirato

4 The Global Station For Quantum Medical Science And Engineering, 
Sapporo, JP 
Experienced in Brain Tumor
4 The Global Station For Quantum Medical Science And Engineering, 
Sapporo, JP 
OverviewLocationsClinical Research

Overview

Hiroki Shirato practices in Sapporo, Japan. Mr. Shirato is rated as an Experienced expert by MediFind in the treatment of Brain Tumor. His top areas of expertise are Cerebral Hypoxia, Nasopharyngeal Carcinoma, Lung Cancer, Mastectomy, and Gastrostomy.

His clinical research consists of co-authoring 224 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of Brain Tumor.

Gender
Male

Locations

4 The Global Station For Quantum Medical Science And Engineering, Sapporo, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Trial of Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)
Trial of Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)
Enrollment Status: Completed
Publish Date: December 19, 2024
Intervention Type: Radiation
Study Phase: Not Applicable
International Randomized Study of Transarterial Chemoembolization (TACE) Versus Stereotactic Body Radiotherapy (SBRT) / Stereotactic Ablative Radiotherapy (SABR) for Residual or Recurrent Hepatocellular Carcinoma After Initial TACE
International Randomized Study of Transarterial Chemoembolization (TACE) Versus Stereotactic Body Radiotherapy (SBRT) / Stereotactic Ablative Radiotherapy (SABR) for Residual or Recurrent Hepatocellular Carcinoma After Initial TACE
Enrollment Status: Terminated
Publish Date: March 12, 2024
Intervention Type: Procedure, Drug, Radiation
Study Drugs: Embolic Agent, lipiodol
Study Phase: Phase 3
View 1 Less Clinical Trial

224 Total Publications

Influence of Non-Index Pain Before Radiation Therapy for Bone Metastases on Post-Treatment QOL: Analyses Based on a Prospective Observational Study of 26 Centers.
Influence of Non-Index Pain Before Radiation Therapy for Bone Metastases on Post-Treatment QOL: Analyses Based on a Prospective Observational Study of 26 Centers.
Journal: International journal of radiation oncology, biology, physics
Published: April 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Shirato's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile